Literature DB >> 2193951

Neurologic disorders associated with HIV infections.

D H Gabuzda1.   

Abstract

At least 60% of patients infected with the human immunodeficiency virus (HIV) develop neurologic disorders. These may be the direct result of human immunodeficiency virus (HIV) infection, opportunistic infections, neoplastic disorders, or cerebrovascular complications. Neurologic diseases associated with HIV infection include encephalopathy, aseptic meningitis, vacuolar myelopathy, peripheral neuropathy, and myopathy. The pathogenesis of these diseases is not known, but it is likely that they will differ. There is evidence that HIV is the etiologic agent of HIV-associated meningitis and subacute encephalitis, but to date there is little evidence to implicate HIV directly as the cause of vacuolar myelopathy, peripheral neuropathies, and myopathies. The results of preliminary clinical studies suggest that treatment with zidovudine (Retrovir) may cause improvement in some patients.

Entities:  

Mesh:

Year:  1990        PMID: 2193951     DOI: 10.1016/0190-9622(90)70168-h

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  6 in total

Review 1.  Clinical pharmacology of zidovudine and other 2',3'-dideoxynucleoside analogues.

Authors:  F Kamali
Journal:  Clin Investig       Date:  1993-05

2.  Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat.

Authors:  M Chowdhury; J P Taylor; C F Chang; J Rappaport; K Khalili
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

Review 3.  Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  Michelle I Wilde; Heather D Langtry
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

4.  Spinal tract pathology in AIDS: postmortem MRI correlation with neuropathology.

Authors:  C G Santosh; J E Bell; J J Best
Journal:  Neuroradiology       Date:  1995-02       Impact factor: 2.804

5.  Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts.

Authors:  Elias G Argyris; Edward Acheampong; Giuseppe Nunnari; Muhammad Mukhtar; Kevin Jon Williams; Roger J Pomerantz
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

6.  TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation.

Authors:  J P Taylor; R Pomerantz; O Bagasra; M Chowdhury; J Rappaport; K Khalili; S Amini
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.